Off-label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis-Reference-Cited by-同舟云学术

Off-label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis

Published:2019-03-25 Issue:10 Volume:49 Page:1293-1300
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Simsek Melek¹^ORCID,Lissenberg-Witte Birgit I.²,van Riswijk Milou L. M.¹,Verschuren Sander¹,Hoentjen Frank³,Oldenburg Bas⁴,Ponsioen Cyriel Y.⁵,van der Woude C. Janneke⁶,van der Meulen Andrea E.⁷,Pierik Marieke⁸,Dijkstra Gerard⁹,de Boer Nanne K. H.¹,

Affiliation:

1. Department of Gastroenterology and Hepatology; Amsterdam UMC, Vrije Universiteit Amsterdam, AG&M research institute; Amsterdam The Netherlands

2. Department of Epidemiology and Biostatistics; Amsterdam UMC, Vrije Universiteit; Amsterdam The Netherlands

3. Department of Gastroenterology and Hepatology; Radboud University Medical Centre; Nijmegen The Netherlands

4. Department of Gastroenterology and Hepatology; University Medical Centre Utrecht; Utrecht The Netherlands

5. Department of Gastroenterology and Hepatology; Amsterdam UMC, Academical Medical Centre; Amsterdam The Netherlands

6. Department of Gastroenterology and Hepatology; Erasmus University Medical Centre; Rotterdam The Netherlands

7. Department of Gastroenterology and Hepatology; Leiden University Medical Centre; Leiden The Netherlands

8. Department of Gastroenterology and Hepatology; Maastricht University Medical Centre; Maastricht The Netherlands

9. Department of Gastroenterology and Hepatology; University Medical Centre Groningen and University of Groningen; Groningen The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15229/fullpdf

Reference22 articles.

1. Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability;Aagaard;Int J Clin Pharm,2018

2. Association of off-label drug use and adverse drug events in an adult population;Eguale;JAMA Intern Med,2016

3. Administration FaD Patents and Exclusivity 2015 https://www.fda.gov/downloads/drugs/developmentapprovalprocess/smallbusinessassistance/ucm447307.pdf

4. Off-label prescribing: a call for heightened professional and government oversight;Dresser;J Law Med Ethics,2009

5. Prescribing, "Off-Label": What should a physician disclose?;Furey;AMA J Ethics,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease;Gut;2023-06-28

2. Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine;Therapeutic Drug Monitoring;2021-02-01

3. Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physician's perspective;Journal of Pharmaceutical Policy and Practice;2020-07-17

4. Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease-Authors’ reply;Alimentary Pharmacology & Therapeutics;2020-06-11

5. Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2020-06-11